Chalifah Fatihah
The global beauty industry has long looked to South Korea as a pioneer of innovative skincare trends, ranging from sheet masks and snail mucin creams to advanced laser treatments and non-surgical thread lifts. However, a controversial new aesthetic procedure originating from East Asia has recently ignited fierce debates across international digital platforms, sparking widespread anxiety, fascination, and regulatory scrutiny. The treatment in question involves a specialized category of skin boosters allegedly utilizing components derived from human cadaveric tissue, colloquially sensationalized across social media channels as the skin booster derived from corpse skin.
As snippets of videos, anecdotal testimonials, and speculative discussions regarding this high-end regenerative treatment went viral across TikTok, Instagram, and X (formerly Twitter), public concern mounted regarding its biological origin, clinical efficacy, and overarching safety profile. Dermatologists, aesthetic practitioners, and regulatory bodies worldwide have been inundated with inquiries about whether injecting processed human tissue into the dermis is safe, ethical, or scientifically sound. In response to the growing panic and misinformation circulating online, medical authorities have stepped forward to demystify the chemical composition, clinical utility, and regulatory standing of these controversial products.
Understanding the Biological Components: What is Human Acellular Dermal Matrix?
To cut through the sensationalism surrounding the viral trend, medical professionals emphasize the need to examine the actual scientific nomenclature behind the treatment. According to the Indonesian Association of Dermatology and Venereology (PERDOSKI), the core ingredient fueling the controversy is known scientifically as human acellular dermal matrix, commonly abbreviated as hADM.
hADM is a processed form of human dermal tissue from which all cellular components—such as fibroblasts and epidermal cells—have been completely removed through rigorous decellularization processes. What remains is a purified scaffold composed primarily of extracellular matrix proteins, predominantly collagen, elastin, and laminin. In legitimate medical applications, this biological matrix serves as a structural framework that can support cellular repopulation, vascularization, and tissue regeneration.
While the term "corpse skin" or "skin from a cadaver" has been weaponized by social media creators for shock value, dermatological experts clarify that the material undergoes intense chemical, enzymatic, and viral inactivation treatments to ensure it is completely non-living, sterile, and immunologically inert before it ever reaches a clinical setting. Despite these stringent processing protocols, the visceral imagery of utilizing human tissue harvested from deceased donors for cosmetic rejuvenation has understandably unsettled everyday consumers.
The Chronology and Rise of the Trend on Social Media
The trajectory of this beauty controversy follows a familiar modern pattern, originating in niche dermatological clinics in Seoul before expanding rapidly into the global digital ecosystem.
The phenomenon began gaining traction in late August 2026, when international beauty influencers and medical tourism vloggers based in South Korea posted documentary-style content detailing high-end regenerative treatments available in upscale Gangnam clinics. These vlogs highlighted cutting-edge skin boosters marketed not merely for surface-level hydration—like traditional hyaluronic acid fillers—but for deep dermal regeneration, tissue thickening, and structural anti-aging.
By early September 2026, shortened clips and poorly translated descriptions of treatments utilizing biological matrices began circulating widely on Western and Southeast Asian social media platforms. The nuance of "cellular decellularization" and "tissue engineering" was frequently lost in translation, replaced by dramatic headlines claiming that individuals were paying thousands of dollars to inject preserved skin harvested from dead bodies into their faces.
By September 16, 2026, public anxiety had reached a crescendo, prompting mainstream health publications and medical associations to formally address the rumors. In Indonesia, where the viral content had begun influencing local aesthetic consumers, leading medical figures found themselves compelled to issue official clarifications to prevent widespread misunderstandings and potential public health risks.
Expert Insights and PERDOSKI’s Official Stance
Addressing the media in Jakarta, Dr. Hanny Nilasari, Chairperson of the Central Board of the Indonesian Association of Dermatology and Venereology (PERDOSKI), provided crucial context regarding the substance and its professional utilization. Speaking on September 16, 2026, Dr. Hanny confirmed that while the biological basis of hADM involves donor human tissue, the exact sourcing protocols remain opaque to external observers.
"So, it is made from a network of skin tissue originating from donors. However, we do not know for certain whether those donors are living donors or deceased donors—cadavers," Dr. Hanny stated during her briefing, as reported by health networks.
Furthermore, Dr. Hanny highlighted a significant information gap within the global dermatological community. She noted that up to the present time, there has been a notable lack of transparent, peer-reviewed scientific publications detailing the exact extraction, processing, and harvesting techniques utilized specifically for these commercial skin booster formulations. Without comprehensive technical data made publicly available by manufacturers, independent medical boards remain cautious.
Crucially, PERDOSKI pointed out a fundamental discrepancy between how hADM is clinically approved to be used versus how it is currently being marketed in the aesthetic sphere. Historically and globally, human acellular dermal matrix has been utilized extensively in reconstructive surgery, severe burn treatments, periodontal procedures, and plastic surgery—such as breast reconstruction or hernia repair—where structural tissue reinforcement is medically necessary.
"The use of hADM tissue itself, in our experience, is predominantly applied in reconstructive medical procedures, rather than for aesthetic treatments," Dr. Hanny explained. Because its primary medical validation lies in reconstruction rather than skin beautification, translating its use directly into superficial anti-aging skin boosters requires rigorous clinical trials and robust scientific validation.
Regulatory Hurdles and Patient Safety Protocols in Indonesia
As globalization and social media allow cosmetic trends to transcend borders almost instantaneously, national regulatory bodies face unique challenges in monitoring and controlling access to experimental or novel beauty procedures. In Indonesia, the integration of any foreign medical device, pharmaceutical agent, or biological aesthetic product is governed by stringent evaluation frameworks overseen by the Indonesian Food and Drug Authority (BPOM) in coordination with professional medical associations like PERDOSKI.
Dr. Hanny emphasized that before any product containing human-derived matrices can be officially cleared for import and commercial distribution in Indonesia, it must clear exceptionally high bars concerning patient safety, ethical sourcing, and legal compliance.
"If, for example, all of those requirements have been fully met, then perhaps we can evaluate whether it can be approved for entry into Indonesia," Dr. Hanny concluded.
At present, no official approvals have been granted for skin boosters utilizing hADM or similar cadaveric-derived matrices for routine aesthetic practices within the country. Consequently, consumers seeking these treatments must look abroad, typically traveling to specialized clinics in South Korea or potentially risking unverified grey-market imports—a practice that health authorities strongly caution against due to the risk of infection, allergic reactions, and lack of recourse if complications arise.
Broader Implications for the Global Aesthetics Market
The viral spread of the hADM skin booster trend highlights a broader cultural and industrial shift within the modern beauty landscape. Consumers are increasingly demanding procedures that promise biological regeneration—harnessing stem cells, growth factors, polynucleotides (such as salmon DNA), and extracellular matrices—rather than temporary fixes like synthetic fillers or superficial moisturizers.
However, this relentless pursuit of eternal youth raises profound bioethical, regulatory, and psychological questions. The normalization of utilizing human tissue for cosmetic enhancement forces society to confront the commercialization of human remains and biological donations. While cadaveric tissue donation has long been accepted and celebrated in life-saving fields such as organ transplantation and cornea donation, its transition into the multi-billion-dollar luxury aesthetic market crosses ethical boundaries for many ethicists and patients alike.
Moreover, the incident underscores the growing power and peril of social media algorithms in shaping consumer health decisions. Misleading terminology can transform advanced biomedical engineering into sensationalized internet horror stories, creating unnecessary panic while simultaneously driving ill-informed consumer demand for unverified procedures.
As research into regenerative medicine continues to evolve, medical communities worldwide will need to establish clearer boundaries between reconstructive tissue engineering and commercial aesthetics. Until independent clinical studies validate the safety, efficacy, and ethical integrity of human-derived dermal matrices in cosmetic skin boosters, medical authorities advise consumers to exercise extreme caution, prioritize evidence-based skincare, and rely exclusively on treatments approved by certified national health regulators.
